Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7XX3

Crystal structure of human Superoxide Dismutase (SOD1) in complex with a fungal metabolite molecule, Phialomustin B (PB)

Summary for 7XX3
Entry DOI10.2210/pdb7xx3/pdb
DescriptorSuperoxide dismutase [Cu-Zn], ZINC ION, GLYCEROL, ... (6 entities in total)
Functional Keywordssuperoxide dismutase, protein aggregation, modulator, toxic trimer, oxidoreductase
Biological sourceHomo sapiens (human)
Total number of polymer chains10
Total formula weight192834.62
Authors
Padmanabhan, B.,Unni, S. (deposition date: 2022-05-28, release date: 2023-12-13, Last modification date: 2025-02-26)
Primary citationUnni, S.,Kommu, P.,Aouti, S.,Nalli, Y.,Bharath, M.M.S.,Ali, A.,Padmanabhan, B.
Structural insights into the modulation Of SOD1 aggregation By a fungal metabolite Phialomustin-B: Therapeutic potential in ALS.
Plos One, 19:e0298196-e0298196, 2024
Cited by
PubMed Abstract: Amyotrophic lateral sclerosis (ALS) is a fatal human motor neuron disease leading to muscle atrophy and paralysis. Mutations in superoxide dismutase 1 (SOD1) are associated with familial ALS (fALS). The SOD1 mutants in ALS have a toxic-gain of function by destabilizing the functional SOD1 homodimer, consequently inducing fibril-like aggregation with a cytotoxic non-native trimer intermediate. Therefore, reducing SOD1 oligomerization via chemical modulators is an optimal therapy in ALS. Here, we report the discovery of Phialomustin-B, an unsaturated secondary metabolite from the endophytic fungus Phialophora mustea, as a modulator of SOD1 aggregation. The crystal structure of the SOD1-Phialomustin complex refined to 1.90 Å resolution demonstrated for the first time that the ligand binds to the dimer interface and the lateral region near the electrostatic loop. The aggregation analyses of SOD1WT and the disease mutant SOD1A4V revealed that Phialomustin-B reduces cytotoxic trimerization. We propose that Phialomustin-B is a potent lead molecule with therapeutic potential in fALS.
PubMed: 38446760
DOI: 10.1371/journal.pone.0298196
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

235458

건을2025-04-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon